ACGT sponsored a "Gene & Cell Therapy for Cancer" symposium at the American Society of Cell and Gene Therapy (ASCGT) Annual Meeting in Salt Lake City, UT, Thursday, May 16th, 2013.
The Symposium included state-of-the-art lectures by leading investigators in four exceptionally promising areas of scientific research and translational development in cell and gene therapy for cancer.
Speakers included ACGT Scientific Advisory Council Members: Dr. Lieping Chen, Yale Cancer Center, Dr. Joseph Glorioso, University of Pittsburgh School of Medicine, Dr. Carl June, University of Pennsylvania and Dr. Stephen Russell, Mayo Clinic; Chaired by Dr. Savio Woo, Mt. Sinai School of Medicine and Dr. Xandra Breakefield, Harvard Medical School.
What is Cell & Gene Therapy?
Why is it important?
Cell and gene therapies for cancer are treatments that attack only cancer cells and have the potential to improve the quality of life and survival for all cancer patients. Learn more...
ACGT funds promising leukemia study with patients in remission more than two years after gene therapy treatment at University of Pennsylvania. Download the ACGT press release (PDF)
PATIENT STORIES
Watch an Amazing Short Film of a Young Girl's Recovery
The innovative treatment using gene therapy – and the dedication of her medical team – is truly inspiring. This study was originally funded by ACGT. This moving film is by Ross Kauffman & DB Productions.
In Girl's Last Hope, Altered Immune Cells Beat Leukemia
Emma Whitehead, 7, has been in full remission for months after scientists used a disabled form of H.I.V. to reprogram her immune system to kill cancer cells. (Photo by Jeff Swensen/NYTimes)
Read the Dec 9, 2012 NYTimes article
Better Quality of Life
"Because of gene therapy I am standing here talking to you tonight," said lung cancer patient Connie Burnett-West.
Read Connie's story...
In His Own Words: Another Patient Lives Because of Gene Therapy
Learn from Dr. Carl June How Your Support of ACGT Made Life-Saving Leukemia Breakthrough Possible
View Our List of Fellows
Every day, thanks to your generosity, ACGT Grantees are making enormous progress in the treatments of Lymphoma, Leukemia, Multiple Myeloma, Neuroblastoma, Breast cancer, Ovarian cancer, Lung cancer, Brain cancer, Pancreatic cancer, and Prostate cancer. View a list of our Grantees.
ACGT is approved by the coalition of the Better Business Bureau and the National Charities Information Bureau. Read more...
Follow us
now on...
Send this page
to a friend